ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,543.22
      1.61%
      US Tech 100
      19,020.80
      0.23%
      Dow Jones
      40,563.06
      1.39%
      Brent Oil
      79.68
      -0.99%
      Bitcoin
      58,372.04
      1.44%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Castle Biosciences Inc (CSTL)

      7. Castle Biosciences Inc (CSTL) News

      CSTL

      Castle Biosciences (CSTL)

      Castle Biosciences Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:CSTL
      DateTimeSourceHeadlineSymbolCompany
      12:04PMiHub NewswireFeaturedPOET Technologies Reports Second Quarter 2024 Financial Results
      08/13/20246:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
      08/13/20246:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
      08/13/20246:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
      08/13/20246:13PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
      08/05/20244:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
      08/05/20244:10PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CSTLCastle Biosciences Inc
      08/05/20244:08PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CSTLCastle Biosciences Inc
      08/05/20244:05PMBusiness WireCastle Biosciences Reports Second Quarter 2024 ResultsNASDAQ:CSTLCastle Biosciences Inc
      08/02/20243:13PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CSTLCastle Biosciences Inc
      07/31/20244:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
      07/30/20247:00AMBusiness WireCastle Biosciences to Present at the Canaccord Genuity 44th Annual Growth ConferenceNASDAQ:CSTLCastle Biosciences Inc
      07/22/20247:00AMBusiness WireCastle Biosciences and Skin Cancer Survivor Teddi Mellencamp Arroyave Launch Campaign to Increase Awareness of MelanomaNASDAQ:CSTLCastle Biosciences Inc
      07/16/20244:51PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
      07/16/20244:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
      07/15/20247:00AMBusiness WireCastle Biosciences to Release Second Quarter 2024 Financial Results and Host Conference Call on Monday, Aug. 5, 2024NASDAQ:CSTLCastle Biosciences Inc
      07/11/20247:00AMBusiness WireCastle Biosciences Honored with Top Workplaces AwardsNASDAQ:CSTLCastle Biosciences Inc
      06/24/20247:00AMBusiness WireRecent AGA Clinical Practice Guideline Acknowledges That Individuals Who May Be at Increased Risk of Progression to Esophageal Cancer Might Be Identified Using Tissue-Based Biomarkers, Particularly Castle Biosciences’ TissueCypher® TestNASDAQ:CSTLCastle Biosciences Inc
      06/20/20247:00AMBusiness WireCastle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CSTLCastle Biosciences Inc
      06/14/20244:30PMBusiness WireCastle Biosciences’ Founder, President and CEO Derek Maetzold Named an EY Entrepreneur Of The Year® 2024 Gulf South Award WinnerNASDAQ:CSTLCastle Biosciences Inc
      06/04/20246:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
      05/30/20244:30PMBusiness WireCastle Biosciences to Present New Data at 2024 ASCO® Annual Meeting Highlighting Use of DecisionDx®-Melanoma to Identify Early-Stage Melanoma Patients at High Risk of Metastasis to the Central Nervous System to Prompt Use of Imaging SurveillanceNASDAQ:CSTLCastle Biosciences Inc
      05/29/20244:44PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
      05/29/20244:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
      05/29/20244:30PMBusiness WireNew Publication Shows DecisionDx®-SCC Identifies High-Risk Squamous Cell Carcinoma Patients Who Are Likely to Benefit from Adjuvant Radiation Therapy and Those Who Can Consider Deferring Treatment Based on Biological Risk of MetastasisNASDAQ:CSTLCastle Biosciences Inc
      05/28/20244:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
      05/28/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
      05/28/20244:13PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
      05/28/20244:08PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSTLCastle Biosciences Inc
      05/24/20244:27PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CSTLCastle Biosciences Inc
       Showing the most relevant articles for your search:NASDAQ:CSTL